Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer

BACKGROUND: Based on their renal excretion, direct oral anticoagulants (DOACs) may increase the risk of hematuria in patients with atrial fibrillation (AF) and urologic cancer compared with vitamin K antagonists. OBJECTIVES: To examine the risk of bleeding associated with DOAC versus warfarin in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ording, Anne Gulbech, Søgaard, Mette, Skjøth, Flemming, Grove, Erik Lerkevang, Lip, Gregory Y. H., Larsen, Torben Bjerregaard, Nielsen, Peter Brønnum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756162/
https://www.ncbi.nlm.nih.gov/pubmed/35059549
http://dx.doi.org/10.1002/rth2.12629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756162/
https://www.ncbi.nlm.nih.gov/pubmed/35059549
http://dx.doi.org/10.1002/rth2.12629

Ejemplares similares